Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/68520
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vinardell Martínez-Hidalgo, Ma. Pilar | - |
dc.contributor.author | Mitjans Arnal, Montserrat | - |
dc.date.accessioned | 2015-12-18T16:15:38Z | - |
dc.date.available | 2015-12-18T16:15:38Z | - |
dc.date.issued | 2015-06-09 | - |
dc.identifier.issn | 2079-4991 | - |
dc.identifier.uri | http://hdl.handle.net/2445/68520 | - |
dc.description.abstract | Nanoparticles have received much attention recently due to their use in cancer therapy. Studies have shown that different metal oxide nanoparticles induce cytotoxicity in cancer cells, but not in normal cells. In some cases, such anticancer activity has been demonstrated to hold for the nanoparticle alone or in combination with different therapies, such as photocatalytic therapy or some anticancer drugs. Zinc oxide nanoparticles have been shown to have this activity alone or when loaded with an anticancer drug, such as doxorubicin. Other nanoparticles that show cytotoxic effects on cancer cells include cobalt oxide, iron oxide and copper oxide. The antitumor mechanism could work through the generation of reactive oxygen species or apoptosis and necrosis, among other possibilities. Here, we review the most significant antitumor results obtained with different metal oxide nanoparticles. | - |
dc.format.extent | 18 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.3390/nano5021004 | - |
dc.relation.ispartof | Nanomaterials, 2015, vol. 5, num. 2, p. 1004-1021 | - |
dc.relation.uri | http://dx.doi.org/10.3390/nano5021004 | - |
dc.rights | cc-by (c) Vinardell Martínez-Hidalgo, Ma. Pilar et al., 2015 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Bioquímica i Fisiologia) | - |
dc.subject.classification | Òxids metàl·lics | - |
dc.subject.classification | Nanopartícules | - |
dc.subject.classification | Càncer | - |
dc.subject.classification | Medicaments antineoplàstics | - |
dc.subject.other | Metallic oxides | - |
dc.subject.other | Nanoparticles | - |
dc.subject.other | Cancer | - |
dc.subject.other | Antineoplastic agents | - |
dc.title | Antitumor activities of metal oxide nanoparticles | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 654194 | - |
dc.date.updated | 2015-12-18T16:15:39Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 28347048 | - |
Appears in Collections: | Articles publicats en revistes (Bioquímica i Fisiologia) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
654194.pdf | 2.36 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License